Company: RGNT
Filing Date: 2025-01-24
Form Type: DRS
Source: 0001213900-25-006245
Chunk: 97

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-01-24
Form: DRS
Chunk 97
---
 our incentive option plan (subject to anti-dilution protection), at an exercise price of NIS 0.01; |

| ● | 80,355 Ordinary Shares issuable upon the exercise of options to consultants and certain investors to be issued upon the completion of this offering under our incentive option plan, at an exercise price of NIS 0.01; |

| ● | Warrants issuable to Bridge Loan (as defined below) lenders to purchase such number of Ordinary Shares equal to two times the respective loan amount of each Bridge Loan lender, based on a price per share equal to 75.0% of the lowest price per share of the Company’ Ordinary Shares during the first five trading days following the consummation of this offering; and |

| ● | Warrants issuable to 2024 Loan Agreements (as defined below) lenders to purchase such number of Ordinary Shares equal to two times the respective loan amount of each 2024 Loan Agreements lender, based on a price per share equal to 75.0% of the lowest price per share of the Company’ Ordinary Shares during the first five trading days following the consummation of this offering. |

<div align='center'>60

DILUTION</div>

If you invest in our Ordinary
Shares in this offering, your interest will be immediately diluted to the extent of the difference between the initial public offering
price per Ordinary Share sold in this offering and the pro forma as adjusted net tangible book value per Ordinary Share after this offering.
Dilution results from the fact that the initial public offering price per Ordinary Share is substantially in excess of the net tangible
book value per Ordinary Share. As of June 30, 2024, we had a historical net tangible book value of $ (38.69) million, or $(596.47) per
Ordinary Share. Our net tangible book value per share represents total tangible assets less total liabilities, divided by which was the
number of Ordinary Shares outstanding on June 30, 2024.

Our pro forma net tangible book value as of June 30, 2024 was $(1,062) million, or $(0.68) per Ordinary Share. Pro forma net tangible book value per share represents total tangible assets less total liabilities, divided by which is the number of Ordinary Shares outstanding as of June 30, 2024, after giving effect to the following events as if each event had occurred on June 30, 2024: (i) the issuance of